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The chemical composition of ethanol extracts from samples of Brazilian propolis (EEPs)
determined by HPLC and their activity against Trypanosoma cruzi, Staphylococcus aureus,
Streptococcus pneumoniae, Klebisiella pneumoniae, Candida albicans, Sporothrix schenckii and
Paracoccidioides brasiliensis were determined. Based on the predominant botanical origin in the
region of samples’ collection, the 10 extracts were separated into three groups:
A( B. dracunculifoliaþAuraucaria spp), B (B. dracunculifolia) and C (Araucaria spp).
Analysis by the multiple regression of all the extracts together showed a positive correlation,
higher concentrations leading to higher biological effect, of S. aureus with p-coumaric acid
(PCUM) and 3-(4-hydroxy-3-(oxo-butenyl)-phenylacrylic acid (DHCA1) and of trypomasti-
gotes of T. cruzi with 3,5-diprenyl-4-hydroxycinnamic acid derivative 4 (DHCA4) and
2,2-dimethyl-6-carboxyethenyl-2H-1-benzopyran (DCBEN). When the same approach was
employed for each group, due to the small number of observations, the statistical test gave
unreliable results. However, an overall analysis revealed for group A an association of S. aureus
with caffeic acid (CAF) and dicaffeoylquinic acid 3 (CAFQ3), of S. pneumoniae with CAFQ3
and monocaffeoylquinic acid 2 (CAFQ2) and of T. cruzi also with CAFQ3. For group B,
a higher activity against S. pneumoniae was associated DCBEN and for T. cruzi with CAF.
For group C no association was observed between the anitmicrobial effect and any component
of the extracts. The present study reinforces the relevance of PCUM and derivatives, especially
prenylated ones and also of caffeolyquinic acids, on the biological activity of Brazilian propolis.
Keywords: bactericidal activity–chemical composition–fungicidal activity–propolis–statistical
analysis–Trypanosoma cruzi
Introduction
Propolis presents a complex composition depending
basically on the plant sources accessible to the bees,
possessing a variety of biological and pharmacologic
activities, attracting the interest of an increasing number
of researchers (1). Brazillian samples present striking
differences in their chemical composition when compared
with samples from temperate zones (2). Besides, differ-
ences are also found among tropical samples depending
on the local flora at the site of collection (3). As examples
we found the Brazilian green or Alecrim propolis,
originated from Baccharis dracunculifolia (Asteraceae)
(4–6), the Cuban red propolis from Clusia nemorosa
(Clusiaceae) (7) and more recently the red propolis
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properly cited.collected in the North region of Brazil (8). While the
microbicidal activity of European propolis has been
associated with the presence of flavonoids and derivatives
of caffeic acid (9,10), in the case of tropical samples, the
main bioactive compounds are phenolic acids and
prenylated derivatives (11).
Due to the increasing interest in the characteristics of
Brazilian propolis, we undertook a study using samples
collected in different regions, aiming to determine their
effect against Trypanosoma cruzi and different species of
bacteria and fungi. Trypanosoma cruzi is the etiologic
agent of Chagas’ disease, an important Public Health
problem in Latin America, the treatment of which is still
inadequate since the available drug benznidazole, a
nitroderivative, causes severe side effects and its efficacy
for chronic patients is questionable (12,13). Streptococcus
pneumoniae and Staphylococcus aureus were assayed
since they can colonize the human nasopharynx and
represent potential agents of several diseases (14,15).
Klebisiella pneumoniae was also included in the
present work. Candida albicans, Sporothrix schenckii
and Paracoccidioides brasiliensis, was selected due
to their importance as etiologic agents of mycosis in
Brazil (16,17).
Materials and Methods
Propolis Extracts
Eleven samples were collected in different regions in
Brazil and 30g of each resin were triturated and extracted
with 100ml ethanol (Merck Darmstadt, Germany) for
20 days in the dark. Afterwards, the material was cooled
for precipitation of waxes, which were removed by
filtration and the extract was dried under reduced
pressure at 60 C. Their yield varied between 40 and
60%. Stock solutions of the eleven extracts were prepared
in dimethylsulfoxide (DMSO). Based on the predominant
botanical origin in the region of samples collection they
were separated as: group A (B. dracunculifolia plus
Auraucaria spp, State of Parana ´ ): EEP-01 to EEP-04;
group B (B. dracunculifolia, State of Minas Gerais):
EEP-05 to EEP-07 and, group C (Auraucaria spp, State
of Parana ´ ) EEP-08 to EEP-10. Another extract obtained
from a red propolis collected in the State of Alagoas,
EEP-11 (Schinus terebinthifolius, Diplotropis incexis and
Manilkara huberi) was also included for the biological
assays (8).
HPLC-MS Analysis
EEP-1 to EEP-10 were analyzed by HPLC (D-7000
Merck-Hitachi, Germany) equipped with a pump (model
L-6200, Merck-Hitachi, Germany) and a diode array
detector (L-3000, Merck-Hitachi, Germany) as previously
described (18). Detection of the components was mon-
itored at 280 and 340nm and standard compounds were
co-chromatographed with the extracts.
1H-NMR and
13C-NMR were recorded using a Varian Gemini 300 spec-
trophotometer and the mass spectra obtained in a
Hewlett–Packard apparatus (model 5890 Series II Plus).
Fungicidal Activity
The agar cup method was used (19) to assay the effect of
the EEPs against C. albicans (Ca IOC-3781), S. schenckii
(Ss IOC-2832) and P. brasiliensis (Pb IOC-3698). Yeast
cells of C. albicans were grown in Sabouraud medium
(Difco Laboratories, Detroit, MI, USA) at 25 C and
yeast-like cells of S. schenckii and P. brasiliensis were
grown in brain heart infusion (BHI) (Difco) and peptone-
yeast extract-glucose (PYG) (Difco) at 36 C. The fungal
cells were washed in phosphate-buffered saline (PBS, pH
7.2) counted in a hemocytometer and the concentration
adjusted to 3.4 10
7 cells ml
 1. A plate of a suitable
sterile agar, poured to a depth of 4mm, was allowed to
set and a single cup (15mm diameter), cut from the
centre of the plate. The cell suspensions (50ml) were
streaked radially from the cup to the edge of the plate on
the suitable agar medium surface for each fungus and the
cup filled with 200ml of EEP (2–16mgml
 1). The plates
were incubated for 3 days at 25 C for C. albicans and for
6 days at 36 C for both S. schenckii and P. brasiliensis.
The antifungal activity was measured as the diameter of
the inhibitory zones. Controls were performed with
DMSO, the solvent of the stock solutions of the extracts;
no inhibition zone was observed. Diameters of less than
15mm were considered as lack of activity.
Bactericidal Activity
The minimal inhibitory concentration (MIC) was deter-
mined by means of the broth microdilution method
described by the National Committee for Clinical
Laboratory Standards (20), followed by subculture.
S. pneumoniae (ATCC 49619), S. aureus (ATCC 25923)
and K. pneumoniae (ATCC 70603) were grown in
Mu ¨ eller-Hinton agar supplemented with 5% sheep
blood and incubated for 18h at 37 C. S. pneumoniae
was incubated in a 5% CO2 atmosphere. Bacterium
inoculum was prepared in Mu ¨ eller-Hinton Broth (Oxoid
Ltd Basingstone, Hampshire, England), adjusted to 0.5
McFarland turbidity standard (10
8 CFU ml
 1) and then
diluted 1:10. This suspension (100ml) was added to equal
volume of the EEP, previously prepared by 2-fold serial
dilutions in 96-well plates. After 18h, subculture (10ml)
from each well was made in the same conditions. MIC
was considered the lowest concentration of the extract
that yields negatives subcultures. The final concentration
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tion of the bacteria.
Trypanocidal Activity
The Y strain of T. cruzi was used (21). Bloodstream
trypomastigotes were obtained at the peak of parasitemia
from infected albino mice, isolated by differential
centrifugation and resuspended with Dulbecco’s modified
Eagle medium (DME) to a parasite concentration of
10 10
6 cellsml
 1 in the presence of 10% blood. This
suspension (100ml) was added to the same volume of
the EEP, previously prepared at twice the desired
concentrations also in DME (0.025–4mg ml
 1)i n
96-well plates and then incubated at 4 C.
Trypomastigote concentration in the wells was 5 10
6
cells ml
 1 containing 5% blood (22). Cell counts were
performed after 24h of incubation and the activity of the
extracts was expressed as IC50 values, corresponding to
the concentration that lysed 50% of the parasites.
Experiments showed that in concentrations up to 0.2%,
DMSO had no deleterious effect on the parasites.
Statistical Analysis
The correlation of the trypanocidal (IC50) or bactericidal
(MIC) activity with the composition of each extract
determined by HPLC, expressed in mg g
 1 of dried
extract (Table 1), was performed by the method of
analysis of multiple regressions using the software SPSS
for Windows 8.0. Positive correlation means that higher
concentrations of a specific component are associated
with higher antimicrobial activity, while negative correla-
tion, means that at lower concentrations a higher activity
was achieved. It is important to note that, for a given
extract, lower values of the parameters IC50 and MIC
indicate a higher activity. The comparison between the
IC50 values for T. cruzi was performed by ANOVA
followed by the Student-Newman–Keuls test (P50.05).
Results
Chemical Composition and Fungicidal Activity
of the Extracts
The chemical composition of each EEP quantified by
HPLC is presented in Table 1. In order to better visualize
the distribution of the components in groups A, B and C
based on the predominant vegetation the concentration
of each component was included in each group expressed
as mean standard deviation (Fig. 1).
The effect of the extracts against C. albicans,
S. schenckii and P. brasiliensis is presented in Fig. 2,
being the latter species the most susceptible to propolis.
No statistical correlation was performed; the values were
expressed in diameter of inhibition zone expressed in mm,
for four different concentrations of each extract.
Bactericidal Activity and Correlation With the
Chemical Composition
The MIC range for S. pneumoniae was 0.2–0.8mgm l
 1
and for S. aureus, 1.6–52.4mgml
 1 (Fig. 3). All the
extracts were inactive against K. pneumoniae. Analysis
by the method of multiple regression of all the extracts
together showed for S. aureus a positive correlation for
p-coumaric acid (PCUM) (P¼0.0002) and 3-(4-hydroxy-
3-(oxo-butenyl)-phenylacrylic acid (DHCA1) (P¼0.006),
meaning higher concentrations of each compound led to
higher bactericidal effect and a negative one for 3-
methoxy-4-hydroxycinnamaldehyde (G2) (P¼0.001) and
vanillin (VAN) (P¼0.026). While for S. pneumoniae,a
negative correlation between the activity and the
concentration of G2 (P¼0.024) was observed. When
the same approach was employed for each group, since
the number of extracts was four, three and three, for
groups A, B and C, respectively, the multiple regression
analysis gave unreliable results. However, an overall
analysis revealed for group A
(B. dracunculifoliaþAuraucaria spp) there was an
association of concentrations of caffeic acid (CAF) and
dicaffeoylquinic acid 3 (CAFQ3) with the activity
against S. aureus, while for S. pneumoniae such
association occurred and between CAFQ3 and mono-
caffeoylquinic acid 2 (CAFQ2). In group B (B.
dracunculifolia) higher activity against S. pneumoniae
was associated with 2,2-dimethyl-6-carboxyethenyl-2H-1-
benzopyran (DCBEN). For group C (Araucaria spp) no
association was observed between the bactericidal effect
and any component of the extracts.
Trypanocidal Activity and Correlation With the
Chemical Composition
The activity of the extracts against bloodstream trypo-
mastigote forms of T. cruzi is shown in Fig. 4. For each
group the order of decreasing activity (P50.05) was:
EEP-014 EEP-02, EEP-044EEP-03, for group A;
EEP-074EEP-05, EEP-06, for group B and
EEP-94EEP-84EEP-10, for group C.
The statistical analysis of all the extracts together and
the activity against T. cruzi showed a positive correlation
with compounds 3,5-diprenyl-4-hydroxycinnamic acid
derivative 4 (DHCA4) (P¼0.004) and DCBEN
(P¼0.039) and a negative one for 2-[1-hydroxymethyl]-
vinyl-6-acetyl-5-hydroxycumarane (I) (P¼0.00008) and
L2 (P¼0.006), a still non-identified compound. As stated
earlier the multiple regression analysis could not be
applied for each separated group of extracts, but there
was a positive association of the trypanocidal activity
with dicaffeoylquinic acid 3 (CAFQ3) for group A and
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Group A Group B Group C
B. dracunculifoliaþAuraucaria spp B. dracunculifolia Auraucaria spp
Compounds EEP-01 EEP-02 EEP-03 EEP-04 EEP-05 EEP-06 EEP-07 EEP-08 EEP-09 EEP-10
3-Prenyl-4-hydroxycinnamic acid
(PHCA)
8.31 2.69 1.42 7.35 16.82 19.95 13.23 0.00 0.00 0.00
2,2-Dimethyl-6-carboxyethenyl-2H-
1-benzopyran (DCBEN)
10.02 3.48 1.54 7.62 0.00 4.80 0.00 0.00 0.00 0.00
2,2-Dimethyl-8-prenyl-2H-1-benzopyran-
6-propenoic acid (DPB)
33.75 11.39 6.41 23.31 27.52 28.66 19.58 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
(DHCA)
20.80 5.03 2.38 26.70 36.13 38.37 33.04 0.00 0.00 0.00
3-(4-Hydroxy-3-(oxo-butenyl)-pheny-
lacrylic acid (DHCA1)
3.10 1.67 0.00 0.95 1.35 1.30 0.83 0.00 0.00 0.00
3-Prenyl-4-(2-methoxypropionyloxy)
cinnamic acid (DHCA2)
2.97 1.29 0.00 2.05 0.06 0.75 2.08 0.00 0.00 0.00
3,5-Dihydroxy-5-prenylcinnamic
(DHCA3)
3.75 1.58 0.00 1.62 0.48 0.08 1.41 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 4 (DHCA4)
2.15 0.08 0.00 1.61 1.37 3.59 5.84 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 5 (DHCA5)
2.96 1.18 0.00 2.43 1.48 0.46 2.69 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 6 (DHCA6)
3.71 1.31 0.00 2.87 3.67 3.07 3.37 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 7 (DHCA7)
0.00 0.00 0.00 0.00 2.43 0.06 2.28 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 8 (DHCA8)
0.00 0.00 0.00 0.00 3.09 7.20 3.73 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 9 (DHCA9)
0.00 0.00 0.00 0.00 9.25 3.75 2.64 0.00 0.00 0.00
3-Hydroxy-2,2-dimethyl-8-prenyl-2H-
1-benzopyran-6-propenoic acid
(DHCA10)
0.00 0.00 0.00 0.00 4.95 5.81 0.00 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 11 (DHCA11)
0.00 0.00 0.00 0.00 5.86 4.85 0.00 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 12 (DHCA12)
0.00 0.00 0.00 0.00 5.24 0.00 0.00 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 13 (DHCA13)
0.00 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00
3,5-Diprenyl-4-hydroxycinnamic acid
derivative 14 (DHCA14)
0.00 0.00 0.00 0.00 3.47 0.00 0.00 0.00 0.00 0.00
p-Coumaric acid (PCUM) 19.07 9.56 0.79 15.42 33.48 32.47 18.81 0.00 0.00 0.00
Caffeic acid (CAF) 2.39 1.54 0.00 0.00 1.35 1.55 2.94 0.00 0.00 0.00
Cinnamic acid derivative 1 (CIN1) 1.58 1.01 0.00 7.07 0.00 0.00 0.00 0.00 5.28 0.00
3-Prenyl-4-dihydrocinnamoyl-oxy-
cinnamic acid (CIN2)
0.00 0.00 0.00 1.42 0.00 0.00 0.00 0.00 0.00 0.00
Benzoic acid (BENZ) 0.00 0.00 6.53 0.00 0.00 0.00 0.00 0.00 24.74 0.00
Monocaffeoylquinic acid 1 (CAFQ1) 7.35 6.35 0.00 6.05 9.79 13.59 4.31 0.00 0.00 0.00
Monocaffeoylquinic acid 2 (CAFQ2) 1.57 1.49 0.00 0.00 4.06 0.00 0.00 0.00 0.00 0.00
Dicaffeoylquinic acid 1 (CAFQ3) 2.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dicaffeoylquinic acid 2 (CAFQ4) 0.61 0.50 0.13 0.37 0.99 1.85 0.63 0.00 0.00 0.00
Pinobanksin (PK) 0.00 0.00 0.00 0.00 45.61 34.92 26.00 0.00 0.00 0.00
Kaempferol (KAEMP) 0.00 0.00 0.00 3.91 0.00 0.00 0.00 0.00 1.60 0.00
Kaempferide (KAEMP1) 20.80 0.00 0.00 11.76 37.05 34.08 33.04 0.00 0.00 0.00
Crysine (CRYS) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.24 0.00
(continued)
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association was observed between the effect against
trypomastigote forms and any component of the extracts.
Discussion
Propolis samples from tropical zones, such as Brazil with
its vast biodiversity, have become a subject of increasing
scientific and economic attention. From Brazilian
propolis, several bioactive derivatives of hydroxycin-
namic, caffeoylquinic and diterpenic acids besides benzo-
furanes and benzopyranes have already been
characterized (18,23–25).
As typical of Brazilian propolis (2), most of the
compounds present in the EEPs were phenolics, being
present in high content hydroxycinnamic acids, such as
PCUM and CAF and their prenylated derivatives. For
group A (B. dracunculifoliaþAraucaria spp), the extracts
are typified as BRP(PR) based on the main bioactive
components DHCA, DCBEN, 3-prenyl-4-hydroxycin-
namic acid (PHCA) and 2,2-dimethyl-8-prenyl-2H-1-
benzopyran-6-propenoic acid (DPB) (26). For group B
(Araucaria spp), they are typified as BRP-1 (26) with the
main components being DHCA, PHCA, DPB, PCUM
and CAF, containing also caffeoylquinic acid
derivatives. The extracts originated from Auraucaria spp
(group C) are characterized as BRG, rich in coniferalde-
hyde compounds (VAN, G2 and I) (26). In relation
to flavonoids, PK (26.0–45.6mgg
 1 of dried extract)
and kaempferide (KAEMP1) (33.0–37.1mgg
 1) were
detected only in the three extracts of group
B. KAEMP1 was also detected in two out of the four
EEPs of group A.
From EEP-11, the most active extract, a red propolis
collected in the State of Alagoas, has been already isolated:
simple phenolics, triterepenoids, isoflavonoids, prenylated
benzophenones and naphtoquinone epoxide (8).
Red colored propolis has been previously reported as
typical in Cuba (7) and in Venezuela (11).
The fungicidal activity of Brazilian propolis has already
been reported (27,28). All the extracts assayed presented
similar activities considering a given fungus species and
an overall analysis shows that P. brasiliensis was more
susceptible to the extracts than C. albicans and S.
schenckii.
As observed with propolis from temperate regions,
Brazilian samples also present a higher activity against
Gram-positive bacteria than Gram-negative ones (29,30),
as observed in the present work using K. pneumoniae.
The relationship of propolis origin, chemical composition
and activity against S. aureus, as observed in the present
study, was in accordance with the reports of other
investigators (31,32). The statistical analysis of all the
extracts together revealed that higher concentrations of
PCUM and DHCA1 are correlated with higher activity
against S. aureus.
The IC50 for the activity against T. cruzi was in the
range of 200–2000mgml
 1, while for the standard drug,
crystal violet, in the same experimental conditions, the
value was 187.0 21.0mgml
 1 (33). Statistical analysis of
all the extracts showed that higher levels of DHCA4 and
DCBEN were associated with higher trypanocidal effect.
The separation of the extracts in groups A, B and C,
decreasing the number of observations in each group,
prevented the application of multiple regression analysis.
However, for S. aureus, S. pneumoniae and T. cruzi,w e
found, always a positive association of the biological
activity with derivatives of PCUM and of caffeolyquinic
acids, which correspond to caffeic acids esterified with
sugar residues.
For both S. aureus and T. cruzi higher levels of
4-hydroxy cinnamic acid and derivatives were associated
with a stronger biological activity, while no correlation
was found between such activities and the content of
flavonoids. DHCA and DCBEN, previously
Table 1. Continued
Group A Group B Group C
B. dracunculifoliaþAuraucaria spp B. dracunculifolia Auraucaria spp
Compounds EEP-01 EEP-02 EEP-03 EEP-04 EEP-05 EEP-06 EEP-07 EEP-08 EEP-09 EEP-10
3-Methoxy-4-hydroxy-benzaldehyde
(VAN)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.48 8.76 22.82
3-Methoxy-4-hydroxycinnamaldehyde
(G2)
0.00 0.00 1.01 5.09 0.00 0.00 0.00 0.72 0.32 2.95
2-[1-Hydroxymethyl]vinyl-6-
acetyl-5-hidroxycumarane (I)
0.00 0.00 2.31 0.00 0.00 0.00 0.00 3.86 0.00 6.19
Galangin (GAL) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.50 0.00
Compound E (E) 48.52 15.48 0.00 43.46 78.00 77.81 56.22 0.00 0.00 0.00
Compound H (H) 0.00 0.00 20.60 0.00 0.00 0.00 0.00 11.61 97.38 17.68
Compound L2 (L2) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.67 0.00 3.61
eCAM 2008;5(3) 321Figure 1. Concentration expressed in mg g
 1 dried extract (mean standard deviation) of individual components of the ethanol extracts of Brazilian
propolis samples separated by botanical origin: (A) group A; (B) group B; (C) group C.
322 Brazilian propolis: composition and antimicrobial activitycharacterized both in Brazilian propolis and in its main
plant source, B. dracunculifolia, were active against T.
cruzi and S. aureus (18,34) and are useful markers to
typify different samples (26).
The association of the chemical composition of propolis
from different geographic regions with biological activ-
ities lead to the identification of active principles,
a fundamental tool to achieve standardization of this
bee product. The present study reinforces the relevance of
PCUM and derivatives, especially prenylated ones and
also of caffeolyquinic acids, on the biological activity of
Brazilian propolis.
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Figure 3. Bactericidal activity of Brazilian propolis extracts expressed as
MIC values in mgm l
 1: (a) Streptococcus pneumoniae; (b)
Staphylococcus aureus.
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Figure 4. Effect of the Brazilian propolis extracts against bloodstream
trypomastigotes of Trypanosoma cruzi after 1day of treatment at 4 C.
The bars represent the standard deviation of at least three independent
experiments. The activity of EEP-01 was higher than that of EEP-02,
EEP-04 and EEP-03 (P50.05); the activity of EEP-07 was higher than
that of EEP-052, EEP-06 (P50.05); the activity of EEP-9 was higher
than that of EEP-8, which has higher than that of EEP-10 (P50.05).
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